+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Assessment of tear concentrations on therapeutic drug monitoring. II. Pharmacokinetic analysis of valproic acid in guinea pig serum, cerebrospinal fluid, and tears



Assessment of tear concentrations on therapeutic drug monitoring. II. Pharmacokinetic analysis of valproic acid in guinea pig serum, cerebrospinal fluid, and tears



Pharmaceutical Research (New York) 18(4): 500-509



Purpose. To quantitatively describe the pharmacokinetics of valproic acid (VPA) in guinea pig serum (total (Cf+b) and free (Cf)), cerebrospinal fluid (CSF) (C)CSF and tears (C)T using a simple kinetic model, and to examine whether (Cf) and (C)CSF can be predicted by (C)T using the resulting pharmacokinetic parameters. Methods. (Cf+b), (Cf), (C)CSF and (C)T were determined after bolus i.v. injection of 10 or 20 mg/kg VPA using GC/ECNCI/MS. Results. (Cf+b) could be quantitatively described by a two compartment model with linear elimination kinetics. (Cf) was separately analyzed using multi-exponential equations. (C)CSF was analyzed using a simple kinetic model in which the CSF compartment is independently connected with the serum compartment by the apparent diffusion constants (KINCSF and KOUTCSF). (C)T was analyzed using the same simple kinetic model used for (C)CSF. The values of (C)CSF and (Cf) in the steady state can be represented by the following equations; (C)CSF = KINCSF/KOUTCSF X (Cf), (Cf) = KOUTT/KINT X (C)T, and indicating that (Cf) and (C)CSF can be predicted by (C)T using the resulting pharmacokinetic parameters. Conclusions. The measurement of (C)T which can be collected non-invasively and estimated the pharmacokinetic parameters for (Cf), (C)CSF, and (C)T might be a very useful method for TDM of VPA.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010209166

Download citation: RISBibTeXText

PMID: 11451038

DOI: 10.1023/a:1011010528642


Related references

Assessment of drug concentrations in tears in therapeutic drug monitoring: I. Determination of valproic acid in tears by gas chromatography/mass spectrometry with EC/NCI mode. Therapeutic Drug Monitoring 22(6): 716-722, 2000

Assessment of tear concentrations on therapeutic drug monitoring. III. Determination of theophylline in tears by gas chromatography/mass spectrometry with electron ionization mode. Drug Metabolism and Pharmacokinetics 18(2): 139-145, 2004

Population pharmacokinetic analysis of theophylline: relationship between serum concentrations and clinical effects in therapeutic drug monitoring. Yakugaku Zasshi 119(11): 861-867, 1999

Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data. Epilepsy Research 59(2-3): 155-165, 2004

Assessment of valproic acid serum-cerebrospinal fluid transport by microdialysis. Pharmaceutical Research (new York). 10(12): 1765-1771, 1993

Antibacterial therapeutic drug monitoring in cerebrospinal fluid: difficulty in achieving adequate drug concentrations. Journal of Neurosurgery 118(2): 297-301, 2013

Impact of age, gender and CYP2C9/2C19 genotypes on dose-adjusted steady-state serum concentrations of valproic acid-a large-scale study based on naturalistic therapeutic drug monitoring data. European Journal of Clinical Pharmacology 72(9): 1099-1104, 2017

The free fraction of valproic acid in tears, saliva, and cerebrospinal fluid. Epilepsia 23(1): 23-26, 1982

Comparison of tear sampling techniques for pharmacokinetic analysis: Ofloxacin concentrations in rabbit tears after sampling with Schirmer tear strips, capillary tubes, or surgical sponges. Journal of Ocular Pharmacology & Therapeutics 16(5): 439-446, 2000

Analysis of the Variables Influencing Valproic Acid Concentration in the Serum and Cerebrospinal Fluid of Chinese Patients After Craniotomy. Therapeutic Drug Monitoring 39(4): 450-456, 2017

Pharmacokinetic aspects of drug effects in vitro: effects of serum protein binding on concentration and teratogenicity of valproic acid and 2-en-valproic acid in whole embryos in culture. Archives of Toxicology 58(4): 239-242, 1986

Serum carbamazepine concentrations in elderly patients: A case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data. Epilepsia 44(7): 923-929, 2003

Therapeutic Drug Monitoring of Valproic Acid in Children: A Prospective Study of The Effect of The Compliance and The Economic Level on the Trough Plasmatic Concentrations and Epileptic Seizures. Therapie 70(5): 415-424, 2015

Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentrations in cerebrospinal fluid. Antimicrobial Agents and ChemoTherapy 38(9): 2111-2115, 1994

Interaction of valproic acid and amitriptyline: analysis of therapeutic drug monitoring data under naturalistic conditions. Journal of Clinical Psychopharmacology 33(4): 561-564, 2014